TABLE 4.
Peptide Number |
Amino Acid Position |
Peptide Sequence | HLA-restriction |
---|---|---|---|
31D | 153–161 | RGAPERQRL | HLA-A0101 |
32D | 158–166 | RQRLLPAAL | HLA-A0101 |
36A | 175–183 | LLSEADVRA | HLA-A0101 |
37C | 182–190 | RALGGLACD | HLA-A0101 |
44C | 217–225 | DQQEAARAA | HLA-A0101 |
45E | 224–232 | AALQGGGPP | HLA-A0101 |
16F | 80–88 | RVRELAVAL | HLA-A0201 |
32E | 159–167 | QRLLPAALA | HLA-A0201 |
44F | 220–228 | EAARAALQG | HLA-A0201 |
45D | 223–231 | RAALQGGGP | HLA-A0201 |
Peripheral blood leukocytes from 2 vaccinated participants demonstrating prolonged disease-free survival were used to screen an overlapping mesothelin peptide library. Shown are the amino acid positions and sequences of the 6 newly identified HLA-A0101 binding (top) and 4 newly identified HLA-A0201 binding (bottom) mesothelin-derived 9mer epitopes.